🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to address the following hypotheses: (i) Anti-P...
Status
Completed
Location
Yale School of Medicine
Start Date
2015-11
Trial ID
NCT02489448
Treatments Being Tested
A phase II trial to evaluate safety and efficacy of adding durvalumab (MEDI...
Status
Unknown
Location
University of Cologne
Start Date
2019-09-30
Trial ID
NCT04159974
Treatments Being Tested
The primary objective of this trial is to evaluate the synergistic effects ...
Status
Unknown
Location
National Cancer Center, Korea
Start Date
2019-07-04
Trial ID
NCT03899610
Treatments Being Tested
Objectives: The investigators will test whether combination of chemoimmunot...
Status
Recruiting
Location
Duke Cancer Institute
Start Date
2024-07-03
Trial ID
NCT05932199
Neoadjuvant durvalumab (MEDI4736) plus docetaxel, oxaliplatin, S-1 (DOS) fo...
Status
Completed
Location
Asan Medical Center
Start Date
2020-05-13
Trial ID
NCT04221555
Treatments Being Tested
This is a phase II randomized, open label study of durvalumab with/ without...
Status
Unknown
Location
Yonsei University Health System, Severance Hospital
Start Date
2019-01-02
Trial ID
NCT03737968
Treatments Being Tested
This early phase I trial studies the side effects of durvalumab and tremeli...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2017-06-13
Trial ID
NCT03132467
Treatments Being Tested
This pilot phase I trial studies the side effects of durvalumab and tremeli...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-03-07
Trial ID
NCT02812420
Treatments Being Tested
In the treatment of localized/locally advanced urothelial cancer, there are...
Status
Completed
Location
ICO Badalona
Start Date
2018-10-25
Trial ID
NCT03472274
Treatments Being Tested
This is an open-label, Phase 1/2 study to evaluate the safety of durvalumab...
Status
Completed
Location
Research Facility
Start Date
2016-06-24
Trial ID
NCT02735239